Pharmacotherapeutic interventions for bipolar disorder type II:

Simple item page
dc.contributor.authorGodman, Brian
dc.contributor.authorGrobler, Christoffel
dc.contributor.authorVan-De-Lisleh, Marianne
dc.contributor.authorWalei, Janney
dc.contributor.authorBarbosa, Wallace Breno
dc.contributor.authorMasselek, Amos
dc.contributor.authorOpondo, Philip
dc.contributor.authorPetrova, Guenka
dc.contributor.authorTachkov, Konstantin
dc.contributor.authorSefah, Israel
dc.contributor.authorAbdulsalimo, Suhaj
dc.contributor.authorAlrasheedy, Alian A.
dc.contributor.authorUnnikrishnanp, Mazhuvancherry Kesavan
dc.contributor.authorGaruoliene, Kristina
dc.contributor.authorBamitaler, Kayode
dc.contributor.authorKibuule, Dan
dc.contributor.authorKalemeera, Francis
dc.contributor.authorFadare, Joseph
dc.contributor.authorKhan, Tanveer Ahmed
dc.contributor.authorHussain, Shahzad
dc.contributor.authorBochenek, Tomasz
dc.contributor.authorKalungia, Aubrey Chichonyi
dc.contributor.authorMwanza, James
dc.contributor.authorMartin, Antony P
dc.contributor.authorHill, Ruaraidh
dc.contributor.authorBarbui, Corrado
dc.date.accessioned2023-08-24T11:37:37Z
dc.date.available2023-08-24T11:37:37Z
dc.date.issued2019
dc.descriptionResearch article
dc.description.abstractIntroduction: Appropriately managing mental disorders is a growing priority across countries in view of the impact on morbidity and mortality. This includes patients with bipolar disorders (BD). Management of BD is a concern as this is a complex disease with often misdiagnosis, which is a major issue in lower and middleincome countries (LMICs) with typically a limited number of trained personnel and resources. This needs to be addressed. Areas covered: Medicines are the cornerstone of managing patients with Bipolar II across countries including LMICs. The choice of medicines, especially antipsychotics, is important in LMICs with high rates of diabetes and HIV. However, care is currently compromised in LMICs by issues such as the stigma, cultural beliefs, a limited number of trained professionals and high patient co-payments. Expert opinion: Encouragingly, some LMICs have introduced guidelines for patients with BD; however, this is very variable. Strategies for the future include addressing the lack of national guidelines for patients with BD, improving resources for mental disorders including personnel, improving medicine availability and patients’ rights, and monitoring prescribing against agreed guidelines. A number of strategies have been identified to improve the treatment of patients with Bipolar II in LMICs, and will be followed up. KEYWORDS: Bipolar disorders; bipolar disorder type II; lower and middle-income countries; health policies; treatment; pharmaceuticals; differential diagnosis
dc.description.sponsorshipSefako Makgatho Health Sciences University, University of Strathclyde, Busitema University
dc.identifier.citationGodman, B., Grobler, C., Van-De-Lisle, M., Wale, J., Barbosa, W. B., Massele, A., ... & Barbui, C. (2019). Pharmacotherapeutic interventions for bipolar disorder type II: addressing multiple symptoms and approaches with a particular emphasis on strategies in lower and middle-income countries. Expert opinion on pharmacotherapy, 20(18), 2237-2255.
dc.identifier.urihttps://doi.org/10.60682/2j3g-xr29
dc.language.isoen
dc.publisherTaylor & Francis
dc.titlePharmacotherapeutic interventions for bipolar disorder type II:
dc.title.alternativeaddressing multiple symptoms and approaches with a particular emphasis on strategies in lower and middle-income countries
dc.typeArticle
Files
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed to upon submission
Description:
Download
Collections
Department of Clinical Phamacology